Dr. Edward S Breakell, MD DABPATH General Practice Medicare: Not Enrolled in Medicare Practice Location: 456 Woodbine Rd, Stamford, CT 06903 Phone: 203-322-2244 |
Dr. Jack V Diteodoro, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 90 Morgan St, Sutie # 303, Stamford, CT 06905 Phone: 203-323-6873 Fax: 203-358-9775 |
Dr. Jillian Finker, N.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 992 High Ridge Rd Fl 3, Stamford, CT 06905 Phone: 516-765-3272 |
Dr. Alan Jule Ranhosky, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 2874 Long Ridge Rd, Stamford, CT 06903 Phone: 203-329-0095 |
Dr. Richard Stephen Sackler, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 201 Tresser Blvd, Stamford, CT 06901 Phone: 203-588-7777 Fax: 561-473-5040 |
News Archive
Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced that it will present at today's 14th Annual Southern California Investor Conference being held at the Island Hotel in Newport Beach, California.
The NIH has reported that many individuals with COVID-19 develop abnormal blood clots from high inflammation, which can lead to serious health complications and mortality.
Patients with hearing, vision, and speech disabilities, who receive care at University of Utah Hospitals & Clinics, will be screened and provided with auxiliary aids and services as required by federal law under a Resolution Agreement reached with the U.S. Department of Health and Human Services (HHS).
Susan G. Komen today announced more than $1.89 million in new grants to seven breast cancer organizations serving the National Capital Region. The announcement came during the Susan G. Komen Global Race for the Cure Media Kickoff Event and Survivor Roundtable marking the official start of activities leading up to the 25th Global Race for the Cure May 10 on the National Mall.
Global Genomics Group and Metabolon today announced that they have entered into a collaboration agreement to investigate biological networks and pathways in order to discover novel biomarkers and pharmaceutical targets for cardiovascular diseases.
› Verified 3 days ago